
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Nup153 CRISPR/Cas9 KO Plasmid (h2) | sc-403206-KO-2 | 20 µg | $397.00 |
NUP153 encodes Nup153, a scaffold nucleoporin of the nuclear pore complex that localizes to the nuclear basket and helps organize nucleocytoplasmic transport. Nup153 contributes to nuclear import/export by coordinating karyopherin-dependent trafficking, and it also interfaces with chromatin at the nuclear periphery to influence gene regulation and higher-order genome organization. Through roles in nuclear envelope architecture, cell cycle progression, and mitotic reassembly of nuclear pores, Nup153 impacts pathways governing transcriptional programs and RNA processing. Dysregulation of nuclear transport and pore complex components, including NUP153, is linked to genome instability and aberrant signaling observed across multiple disease contexts, making it a relevant target for mechanistic studies.
Nup153 CRISPR/Cas9 KO Plasmid (h2) is a pool of plasmids designed for targeted disruption of the NUP153 gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the NUP153 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the NUP153 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish Nup153 protein expression.
This CRISPR knockout system enables efficient generation of NUP153-deficient cell models for investigation of Nup153 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.